4//SEC Filing
Bellini Roberto 4
Accession 0000950170-25-023594
CIK 0001750149other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:18 PM ET
Size
7.3 KB
Accession
0000950170-25-023594
Insider Transaction Report
Form 4
Bellini Roberto
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-14+73,580→ 73,580 totalExercise: $2.35Exp: 2035-02-14→ Common Stock (73,580 underlying) - Award
Stock Option (Right to Buy)
2025-02-14+116,585→ 116,585 totalExercise: $2.35Exp: 2035-02-14→ Common Stock (116,585 underlying)
Footnotes (2)
- [F1]The options vested and became exercisable on February 14, 2025.
- [F2]The options will vest and become exercisable in two equal annual installments on October 24, 2025 and October 24, 2026.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001802453
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:18 PM ET
- Size
- 7.3 KB